BioCryst Pharmaceuticals Inc (BCRX)
5.325
-0.02
(-0.28%)
USD |
NASDAQ |
May 10, 16:00
5.325
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap: 1.099B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 09, 2024 | 1.102B |
May 08, 2024 | 1.053B |
May 07, 2024 | 1.086B |
May 06, 2024 | 1.088B |
May 03, 2024 | 918.38M |
May 02, 2024 | 924.57M |
May 01, 2024 | 943.14M |
April 30, 2024 | 852.34M |
April 29, 2024 | 881.03M |
April 26, 2024 | 858.34M |
April 25, 2024 | 858.34M |
April 24, 2024 | 868.65M |
April 23, 2024 | 903.73M |
April 22, 2024 | 909.92M |
April 19, 2024 | 914.04M |
April 18, 2024 | 928.49M |
April 17, 2024 | 944.99M |
April 16, 2024 | 951.18M |
April 15, 2024 | 963.56M |
April 12, 2024 | 984.28M |
April 11, 2024 | 1.052B |
April 10, 2024 | 1.005B |
April 09, 2024 | 990.47M |
April 08, 2024 | 951.26M |
April 05, 2024 | 949.20M |
Date | Value |
---|---|
April 04, 2024 | 949.20M |
April 03, 2024 | 976.02M |
April 02, 2024 | 967.77M |
April 01, 2024 | 1.042B |
March 28, 2024 | 1.047B |
March 27, 2024 | 1.062B |
March 26, 2024 | 1.033B |
March 25, 2024 | 1.012B |
March 22, 2024 | 1.033B |
March 21, 2024 | 1.132B |
March 20, 2024 | 1.128B |
March 19, 2024 | 1.105B |
March 18, 2024 | 1.045B |
March 15, 2024 | 1.031B |
March 14, 2024 | 1.008B |
March 13, 2024 | 1.060B |
March 12, 2024 | 1.060B |
March 11, 2024 | 1.097B |
March 08, 2024 | 1.119B |
March 07, 2024 | 1.068B |
March 06, 2024 | 1.074B |
March 05, 2024 | 1.115B |
March 04, 2024 | 1.136B |
March 01, 2024 | 1.159B |
February 29, 2024 | 1.161B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
175.04M
Minimum
Nov 14 2019
3.649B
Maximum
Feb 16 2022
1.506B
Average
1.400B
Median
Jul 31 2023
Market Cap Benchmarks
Integra Lifesciences Holdings Corp | 2.046B |
Krystal Biotech Inc | 4.413B |
AIM ImmunoTech Inc | 20.13M |
Protalix BioTherapeutics Inc | 81.09M |
Armata Pharmaceuticals Inc | 102.29M |
Market Cap Related Metrics
PS Ratio | 2.946 |
Price | 5.325 |
Earnings Yield | -20.09% |